Cargando…
P1167: TREATMENT OF RELAPSED/REFRACTORY HGBCL WITH MYC REARRANGEMENT: A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF PC-002(SEPB),A FIRST-IN-CLASS INHIBITOR OF DEUBIQUITINASES TARGETING MYC DEGRADATION
Autores principales: | Yoon, Sung-Soo, LI, Zhiming, Zhou, Keshu, Zhou, Xiaoxi, Guo, Ye, Zhang, Huilai, Eom, Ki-Seong, Jin Kim, Seok, Yong Oh, Sung, Lim, Sungnam, Youssoufian, Hagop, Jiang, Vernon C, Huang, Zanchun, Kilfoil, Georgina, Wang, Xin, Cao, Zhixiang, LI, Xiang, Wu, Alexander, Chen, Yiyou, Song, Yuqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431014/ http://dx.doi.org/10.1097/01.HS9.0000971564.58268.80 |
Ejemplares similares
-
The Plague of 1167
Publicado: (1895) -
Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination
por: Fang, Xiaoguang, et al.
Publicado: (2017) -
Deubiquitinase USP18 promotes the progression of pancreatic cancer via enhancing the Notch1-c-Myc axis
por: Feng, Long, et al.
Publicado: (2020) -
C-myc and N-myc in the developing brain
por: Wey, Alice, et al.
Publicado: (2010) -
MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
por: Nwanze, Julum, et al.
Publicado: (2017)